Ariad Pharm Inc (ARIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Sales | 74 | 85 | 318 | 81 | 77 |
| Gross Profit | 74 | 85 | 318 | 81 | 77 |
| Operating Expenses | 60,603 | 53,304 | 51,649 | 40,062 | 31,768 |
| Operating Income | -60,529 | -53,219 | -51,331 | -39,981 | -31,691 |
| Interest Expense | 45 | 47 | 50 | 57 | 60 |
| Other Income | 121 | 53 | 69 | -15,856 | -20,051 |
| Pre-tax Income | -60,453 | -53,213 | -51,312 | -55,894 | -51,802 |
| Net Income Continuous | -60,453 | -53,213 | -51,312 | -55,894 | -51,802 |
| Net Income | $-60,453 | $-53,213 | $-51,312 | $-55,894 | $-51,802 |
| EPS Basic Total Ops | -0.36 | -0.32 | -0.31 | -0.35 | -0.38 |
| EPS Basic Continuous Ops | -0.36 | -0.32 | -0.31 | -0.35 | -0.38 |
| EPS Diluted Total Ops | -0.36 | -0.32 | -0.31 | -0.35 | -0.38 |
| EPS Diluted Continuous Ops | -0.36 | -0.32 | -0.31 | -0.35 | -0.38 |
| EBITDA(a) | $-59,716 | $-52,385 | $-45,693 | $-38,959 | $-30,670 |